Goserelin
Gonadotropin Releasing Hormone Analogues
Sold as ZOLADEX · ZOLADEX LA
- Drug class
- Gonadotropin Releasing Hormone Analogues
- Availability
- See label
- Routes
- Subcutaneous
- Markets covered
- 2
- Products on record
- 25
Overview
Goserelin is an active pharmaceutical ingredient in the Gonadotropin Releasing Hormone Analogues group (L02AE). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 23 | May 1, 2026 |
| CA Canada | Health Canada | 2 | March 22, 2025 |
GBUnited Kingdom· MHRA
23 products
Uses
8 mg is indicated in the management of oestrogen- receptor (ER) positive early and advanced breast cancer in pre and peri menopausal women.
How to take
CACanada· Health Canada
2 products
Uses
05/2024 TABLE OF CONTENTS Sections or subsections that are not applicable at the time of authorization are not listed. RECENT MAJOR LABEL CHANGES .........................................................................................
2 TABLE OF CONTENTS ............................................................................................................... 2 PART I: HEALTH PROFESSIONAL INFORMATION ..................................................................
4 1 INDICATIONS ................................................................................................................... 1 Pediatrics .................................................................................................................
2 Geriatrics ................................................................................................................. 4 2 CONTRAINDICATIONS ...................................................................................................
Drug interactions
Known interactions involving Goserelin. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 351. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL179010065 · revised February 20, 2026
- [2]Health Canada (DPD) · 02225905 · revised March 22, 2025
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.